tiziana-logo.png
Tiziana Life Sciences Announces Live Bloomberg TV Interview of Renowned Scientist Dr. Howard L. Weiner to Discuss FDA IND Clearance for Intranasal Foralumab in Alzheimer's Disease
17 août 2023 07h00 HE | Tiziana Life Sciences Ltd.
NEW YORK, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
NFI announces delivery of the 1,500th electric bus from the BYD–Alexander Dennis partnership to customer Go-Ahead London
NFI Group Inc. announces delivery of the 1,500th electric bus from the BYD–Alexander Dennis partnership
08 août 2023 07h30 HE | NFI Group Inc
LARBERT, United Kingdom, Aug. 08, 2023 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader...
Joel_Amanda_Headshot
Team One Announces New Leadership for Dallas Office
03 août 2023 09h45 HE | Team One
Team One Appoints Next Generation Leaders; Putting Creativity and Collaboration on A Pedestal with Organizational Moves. LOS ANGELES, Aug. 03, 2023 (GLOBE NEWSWIRE) -- As an agency that began as a...
Pfizer’s Litfulo Poi
Pfizer’s Litfulo Poised to Follow Similar Trajectory as Eli Lilly/Incyte’s Olumiant for the Treatment of Severe Alopecia Areata
11 juil. 2023 09h58 HE | Spherix Global Insights
Exton, Pennsylvania, July 11, 2023 (GLOBE NEWSWIRE) -- In June 2022, Eli Lilly and Incyte’s Olumiant became the first and only approved advanced systemic treatment for adults with severe alopecia...
NFI Group Inc. - BYD–Alexander Dennis Enviro200EV for Go-Ahead London
NFI announces additional order from Go-Ahead London for 141 electric buses from the BYD–Alexander Dennis partnership
06 juil. 2023 08h16 HE | NFI Group Inc
LARBERT, United Kingdom, July 06, 2023 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a...
tiziana-logo.png
Tiziana Life Sciences to File Alzheimer’s IND for Intranasal Foralumab in Q2 2023
20 avr. 2023 07h00 HE | Tiziana Life Sciences Ltd.
Application for $3M of non-dilutive funding for Phase 2a Alzheimer’s trial will be submitted in Q2 2023Tiziana guided by FDA Type “B” meeting comments on its scheduled Q2 2023 intranasal foralumab...
NFI Group-BYD–Alexander Dennis Enviro400EV for National Express West Midlands (1)
NFI subsidiary Alexander Dennis receives repeat electric bus order from National Express West Midlands for 170 double deck buses
13 avr. 2023 08h00 HE | NFI Group Inc
LARBERT, Scotland and IVER, United Kingdom, April 13, 2023 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach...
tiziana-logo.png
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer’s Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer’s and Parkinson’s Disease and Related Neurological Disorders Conference in Sweden
31 mars 2023 07h00 HE | Tiziana Life Sciences Ltd.
Data shows reduction of microglia activation and improvement in behavior in rodent model of Alzheimer’s disease (AD)Modulation of neuroinflammation may be synergistic to existing treatments in AD NEW...
PlayMining_product_placement_NFTs
PlayMining GameFi Platform Unveils Revolutionary “Product Placement NFT” Advertising Solution
14 mars 2023 03h30 HE | PlayMining
SINGAPORE, March 14, 2023 (GLOBE NEWSWIRE) -- Digital Entertainment Asset (DEA), a Singapore-based global Web3 entertainment company, has launched ‘Product Placement NFTs’ as a new advertising...
Browsi Logo
Browsi Announces Corporate Rebrand Reflecting Expansion Into Video and Becoming an All-in-One Ad Platform
17 nov. 2022 09h00 HE | browsi
NEW YORK, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Leading AI-driven SaaS company Browsi LTD (Headquarters: Tel Aviv, Israel & New York, USA; CEO: Asaf Shamly) today announced a corporate rebranding...